This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound for improving healing and closure of chronic lower extremity wounds (i.e., diabetic foot ulcers [DFUs], venous ulcers, and ischemic/arterial insufficiency ulcers).